Page results
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
-
UCLH consultant neurologist Dr Catherine Mummery has been announced as the new Chair of the NIHR Dementia Translational Research Collaboration.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
UCLH has achieved excellent results in the 2024 National Adult Inpatient Survey, with patients rating their overall care 8.4 out of 10. This gives UCLH the second highest score of London’s acute teaching hospitals.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
-
A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.
-
A quicker, cheaper MRI scan is just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCLH, UCL and the University of Birmingham.
File results
-
FOI/2023/0654 - Email encryption/ E-signature suppliers
-
FOI/2023/0655 - Customer Relationship Management (CRM) system
-
FOI/2023/0658 - Policies/procedures for Non-emergency patient transport services
-
FOI/2023/0662 - NEPTS and patient transport services
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage
-
FOI/2023/0681 - Patient friends and family test supplier
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)